Apellis Pharmaceuticals Shares Are Trading Higher After the European Medicines Agency Resets Pegcetacoplan Review for Geographic Atrophy to Day 180 of Initial Assessment
在欧洲药品管理局将Pegcetacoplan的地理萎缩审查重置为初步评估的第180天后,Apellis Pharmicals的股价走高
Apellis Pharmaceuticals Shares Are Trading Higher After the European Medicines Agency Resets Pegcetacoplan Review for Geographic Atrophy to Day 180 of Initial Assessment
在欧洲药品管理局将Pegcetacoplan的地理萎缩审查重置为初步评估的第180天后,Apellis Pharmicals的股价走高
使用浏览器的分享功能,分享给你的好友吧